
Mrudula Kulkarni | Jun 22, 2026

Mrudula Kulkarni | Jun 18, 2026

Simantini Singh Deo | Jun 16, 2026
Inside PMITS Ahmedabad, 7 July 2026. 130 delegates, India's top pharma manufacturing IT leaders, on MES, CSA, GAMP 5, and the paperless transition.

GAMP 5 Ed.2 recalibrates MES validation around risk, not paperwork. Here's the practical classification framework pharma teams need.

mRNA vaccines proved the science works. Scaling RNA therapeutics manufacturing is the real challenge, 7 bottlenecks the industry faces.

1,200+ nanomedicine trials are active globally, yet only 50-80 have reached approval. The regulatory gaps pharma must solve.

Cost of Quality in pharma explained — PAF model, COPQ benchmarks, real biotech case study, key metrics and how eQMS reduces quality failure costs.
